Faron Pharmaceuticals OY (FARN) NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
224.00p
225.00p
360.00p
£233.31 million
224.00p
216.00p
89.00p
n/a
1.00p (0.44%) Previous:
1.00p
9,215
n/a
750
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (€m) | n/a | n/a |
Profit before tax (€m) | (30.94) | (28.73) |
Adjusted EPS (¢): | (48.00) | (52.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: Euro
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Faron Pharmaceuticals candidate gets FDA fast track designation
27 August 2024 13:00
-
Faron gets positive FDA feedback on bexmarilimab study plans
11 July 2024 11:48
-
Faron Pharmaceuticals extends funding agreement with IPF
30 April 2024 16:33
-
Grant of options
30 August 2024 07:00
-
FDA Grants Fast Track Designation for Bexmarilimab
27 August 2024 07:00
-
Faron 2024 Half-Year Financial Results
27 August 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.